The Sabin Vaccine Institute is interested in your feedback on the Decade of Vaccines Global Vaccine Action Plan (GVAP).

Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world

Novartis today announced that it has entered into a development and licensing agreement with Biological E Limited (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.

Continue reading. 

As part of his role as ROTA Council co-chair, Dr. Ciro de Quadros recently wrote an opinion piece for AllAfrica.com about a new study showing that rotavirus vaccines will have a powerful public health impact in developing countries.

Pages

Subscribe to RSS - Vaccine Advocacy and Education